ODDB.org: Open Drug Database

A. Menarini GmbH - Ranexa 375 mg, Retardtabletten

Swissmedic Registration	60533	Sequence	01
Product name	Ranexa 375 mg	Description	Retardtabletten
ATC-Classification	C01EB18	ATC-Description	Ranolazine
Introduction of Sequence	13.04.2010

Composition

ranolazinum 375 mg, cellulosum microcristallinum, acidi methacrylici et methylis methacrylatis polymerisatum 1:1, hypromellosum, magnesii stearas, natrii hydroxidum corresp. natrium 1.15 mg, Überzug: hypromellosum, macrogolum 400, polysorbatum 80, cera carnauba, E 171, E 132, pro compresso obducto.

Packungsbestandteile

Galenic Form

Delayed release tablets

Active Agent	Dose
	375 mg

BAG: Active Agent	Dose
	375 mg

Inactive agents	Dose	additional_information



		color.
		color.
Hypromellosum		Überzug
Macrogol	400


Sodium Hydroxide
Polysorbatum 80

Package number	Package Size	EFP	CP	Category	SL	Out of trade (MedRef)
001	30 Tablet(s)	PR	PR	B		Yes
002	60 Tablet(s)	46.44	66.90	B	SL	No
003	100 Tablet(s)	75.95	99.00	B	SL	No

2025	©ywesee GmbH